These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6981093)

  • 1. Treatment of cell-mediated immunodeficiency with calf thymic hormone (T.P.I.).
    Davies EG; Levinsky RJ
    Pediatr Res; 1982 Jul; 16(7):573-8. PubMed ID: 6981093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic and clinical investigation on a bovine thymic extract. Therapeutic applications in primary immunoedificiencies.
    Aiuti F; Ammirati P; Fiorilli M; D'Amelio R; Franchi F; Calvani M; Businco L
    Pediatr Res; 1979 Jul; 13(7):797-802. PubMed ID: 314621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin activity in patients with cellular immunodeficiency.
    Wara DW; Goldstein AL; Doyle NE; Ammann AJ
    N Engl J Med; 1975 Jan; 292(2):70-4. PubMed ID: 1078552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of combined immunodeficiency with thymic extract (Thymostimulin).
    Lin CY; Hsu HC; Chen CL; Shen EY
    Ann Allergy; 1987 May; 58(5):379-84. PubMed ID: 3578932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic hormone dependent immunodeficiency in an infant with partial trisomy of chromosome 22.
    Tovo PA; Davi G; Fraceschini P; Delpiano A
    Thymus; 1986; 8(5):313-8. PubMed ID: 3798528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D
    Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency).
    Berthet F; Le Deist F; Duliege AM; Griscelli C; Fischer A
    Pediatrics; 1994 Feb; 93(2):265-70. PubMed ID: 8121739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo effects of thymic hormones (Imunotim) on immunologic parameters of patients with secondary immunodeficiency diseases.
    Crişan M; Stugren C; Gal O; Herold A; Bucurenci N
    Roum Arch Microbiol Immunol; 1992; 51(4):213-24. PubMed ID: 1304826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired production of interleukins in patients with cell-mediated immunodeficiencies.
    Paganelli R; Aiuti F; Beverley PC; Levinsky RJ
    Clin Exp Immunol; 1983 Feb; 51(2):338-44. PubMed ID: 6601554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for B- and T-cell defects in Egyptian infants and children with suspected primary immunodeficiency.
    Hossny E; El-Awady H; El-Feky M; El-Owaidy R
    Med Sci Monit; 2009 May; 15(5):CR217-25. PubMed ID: 19396036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of abnormalities in expression of thymic epithelial surface antigens in severe cellular immunodeficiency diseases.
    Haynes BF; Warren RW; Buckley RH; McClure JE; Goldstein AL; Henderson FW; Hensley LL; Eisenbarth GS
    J Immunol; 1983 Mar; 130(3):1182-8. PubMed ID: 6600476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient hosts.
    Aiuti F; Sirianni MC; Paganelli R; Stella A; Turbessi G; Fiorilli M
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):81-6. PubMed ID: 6341261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity during natural measles infection.
    Whittle HC; Dossetor J; Oduloju A; Bryceson AD; Greenwood BM
    J Clin Invest; 1978 Sep; 62(3):678-84. PubMed ID: 308511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunocorrective therapy of pyelonephritis in children].
    Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
    Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune defect diseases in childhood].
    Zintl F
    Z Gesamte Inn Med; 1977 Oct; 32(20):523-8. PubMed ID: 74137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
    Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
    J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ; Davies EG; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency.
    Reece ER; Gartner JG; Seemayer TA; Joncas JH; Pagano JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4243-7. PubMed ID: 6272969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.